{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T03:24:37Z","timestamp":1789269877690,"version":"build-2803163510"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T00:00:00Z","timestamp":1609718400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T00:00:00Z","timestamp":1609718400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["HHSN316201300006W\/HHSN27200002"],"award-info":[{"award-number":["HHSN316201300006W\/HHSN27200002"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008386","name":"Marmara \u00dcniversitesi","doi-asserted-by":"publisher","award":["SAG-C-TUP-230119-0018"],"award-info":[{"award-number":["SAG-C-TUP-230119-0018"]}],"id":[{"id":"10.13039\/501100008386","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Turkish National Society of Allergy and Clinical Immunology"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1038\/s41590-020-00830-z","type":"journal-article","created":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T12:07:03Z","timestamp":1609762023000},"page":"128-139","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Broadly effective metabolic and immune recovery with C5 inhibition in CHAPLE disease"],"prefix":"10.1038","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9065-1901","authenticated-orcid":false,"given":"Ahmet","family":"Ozen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurhan","family":"Kasap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8611-4900","authenticated-orcid":false,"given":"Ivan","family":"Vujkovic-Cvijin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Apps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Foo","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif","family":"Karakoc-Aydiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilge","family":"Akkelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinan","family":"Sari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Engin","family":"Tutar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Figen","family":"Ozcay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilara Kocacik","family":"Uygun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Islek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gamze","family":"Akgun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merve","family":"Selcuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oya Balci","family":"Sezer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunsel","family":"Kutluk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erdem","family":"Topal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ersin","family":"Sayar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cigdem","family":"Celikel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roderick H. J.","family":"Houwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysen","family":"Bingol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail","family":"Ogulur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevgi Bilgic","family":"Eltan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew L.","family":"Snow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Lake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Fantoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Alba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Sellers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0232-751X","authenticated-orcid":false,"given":"Samuel D.","family":"Chauvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifton L.","family":"Dalgard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Harari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan G.","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Dauh","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kishor","family":"Devalaraja-Narashimha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4371-7290","authenticated-orcid":false,"given":"Poorani","family":"Subramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabia","family":"Ergelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reha","family":"Artan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukru Nail","family":"Guner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Buket","family":"Dalgic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9962-3571","authenticated-orcid":false,"given":"Yasmine","family":"Belkaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deniz","family":"Ertem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safa","family":"Baris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1584-468X","authenticated-orcid":false,"given":"Michael J.","family":"Lenardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,4]]},"reference":[{"key":"830_CR1","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0016-5085(19)35130-3","volume":"41","author":"TA Waldmann","year":"1961","unstructured":"Waldmann, T. A., Steinfeld, J. L., Dutcher, T. F., Davidson, J. D. & Gordon, R. S. Jr. The role of the gastrointestinal system in \u2018idiopathic hypoproteinemia\u2019. Gastroenterology 41, 197\u2013207 (1961).","journal-title":"Gastroenterology"},{"key":"830_CR2","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1056\/NEJMoa1615887","volume":"377","author":"A Ozen","year":"2017","unstructured":"Ozen, A. et al. CD55 deficiency, early-onset protein-losing enteropathy, and thrombosis. N. Engl. J. Med. 377, 52\u201361 (2017).","journal-title":"N. Engl. J. Med."},{"key":"830_CR3","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1056\/NEJMc1707173","volume":"377","author":"A Kurolap","year":"2017","unstructured":"Kurolap, A. et al. Loss of CD55 in eculizumab-responsive protein-losing enteropathy. N. Engl. J. Med. 377, 87\u201389 (2017).","journal-title":"N. Engl. J. Med."},{"key":"830_CR4","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/imr.12715","volume":"287","author":"A Ozen","year":"2019","unstructured":"Ozen, A. CHAPLE syndrome uncovers the primary role of complement in a familial form of Waldmann\u2019s disease. Immunol. Rev. 287, 20\u201332 (2019).","journal-title":"Immunol. Rev."},{"key":"830_CR5","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1007\/s10495-010-0530-8","volume":"15","author":"D Mevorach","year":"2010","unstructured":"Mevorach, D. Clearance of dying cells and systemic lupus erythematosus: the role of C1q and the complement system. Apoptosis 15, 1114\u20131123 (2010).","journal-title":"Apoptosis"},{"key":"830_CR6","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1146\/annurev-immunol-032713-120154","volume":"32","author":"VM Holers","year":"2014","unstructured":"Holers, V. M. Complement and its receptors: new insights into human disease. Annu Rev. Immunol. 32, 433\u2013459 (2014).","journal-title":"Annu Rev. Immunol."},{"key":"830_CR7","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s12026-012-8327-1","volume":"54","author":"WH Kwan","year":"2012","unstructured":"Kwan, W. H., van der Touw, W. & Heeger, P. S. Complement regulation of T cell immunity. Immunol. Res 54, 247\u2013253 (2012).","journal-title":"Immunol. Res"},{"key":"830_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/imr.12474","volume":"274","author":"M Elvington","year":"2016","unstructured":"Elvington, M., Liszewski, M. K. & Atkinson, J. P. Evolution of the complement system: from defense of the single cell to guardian of the intravascular space. Immunol. Rev. 274, 9\u201315 (2016).","journal-title":"Immunol. Rev."},{"key":"830_CR9","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/nri2620","volume":"9","author":"PF Zipfel","year":"2009","unstructured":"Zipfel, P. F. & Skerka, C. Complement regulators and inhibitory proteins. Nat. Rev. Immunol. 9, 729\u2013740 (2009).","journal-title":"Nat. Rev. Immunol."},{"key":"830_CR10","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1038\/nbt1344","volume":"25","author":"RP Rother","year":"2007","unstructured":"Rother, R. P., Rollins, S. A., Mojcik, C. F., Brodsky, R. A. & Bell, L. Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria. Nat. Biotechnol. 25, 1256\u20131264 (2007).","journal-title":"Nat. Biotechnol."},{"key":"830_CR11","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.molimm.2013.05.224","volume":"56","author":"EK Wong","year":"2013","unstructured":"Wong, E. K., Goodship, T. H. & Kavanagh, D. Complement therapy in atypical haemolytic uraemic syndrome (aHUS). Mol. Immunol. 56, 199\u2013212 (2013).","journal-title":"Mol. Immunol."},{"key":"830_CR12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.molimm.2018.06.008","volume":"102","author":"CL Harris","year":"2018","unstructured":"Harris, C. L., Pouw, R. B., Kavanagh, D., Sun, R. & Ricklin, D. Developments in anti-complement therapy; from disease to clinical trial. Mol. Immunol. 102, 89\u2013119 (2018).","journal-title":"Mol. Immunol."},{"key":"830_CR13","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1097\/MPG.0000000000002198","volume":"68","author":"A Kurolap","year":"2019","unstructured":"Kurolap, A. et al. Eculizumab is safe and effective as a long-term treatment for protein-losing enteropathy due to CD55 deficiency. J. Pediatr. Gastroenterol. Nutr. 68, 325\u2013333 (2019).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"830_CR14","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1093\/ecco-jcc\/jjy190","volume":"13","author":"AF Di Narzo","year":"2019","unstructured":"Di Narzo, A. F. et al. High-throughput identification of the plasma proteomic signature of inflammatory bowel disease. J. Crohns Colitis 13, 462\u2013471 (2019).","journal-title":"J. Crohns Colitis"},{"key":"830_CR15","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/imr.12567","volume":"279","author":"JM Pickard","year":"2017","unstructured":"Pickard, J. M., Zeng, M. Y., Caruso, R. & N\u00fa\u00f1ez, G. Gut microbiota: role in pathogen colonization, immune responses, and inflammatory disease. Immunol. Rev. 279, 70\u201389 (2017).","journal-title":"Immunol. Rev."},{"key":"830_CR16","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.jpeds.2010.02.046","volume":"157","author":"A Schwiertz","year":"2010","unstructured":"Schwiertz, A. et al. Microbiota in Pediatric Inflammatory Bowel Disease. J. Pediatr. 157, 240\u2013244.e1 (2010).","journal-title":"J. Pediatr."},{"key":"830_CR17","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.4049\/jimmunol.1402956","volume":"194","author":"JL Giles","year":"2015","unstructured":"Giles, J. L., Choy, E., van den Berg, C., Morgan, B. P. & Harris, C. L. Functional analysis of a complement polymorphism (rs17611) associated with rheumatoid arthritis. J. Immunol. 194, 3029\u20133034 (2015).","journal-title":"J. Immunol."},{"key":"830_CR18","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/ng1599","volume":"37","author":"S Hillebrandt","year":"2005","unstructured":"Hillebrandt, S. et al. Complement factor 5 is a quantitative trait gene that modifies liver fibrogenesis in mice and humans. Nat. Genet. 37, 835\u2013843 (2005).","journal-title":"Nat. Genet."},{"key":"830_CR19","doi-asserted-by":"publisher","first-page":"337","DOI":"10.4049\/jimmunol.1600280","volume":"197","author":"JA Schatz-Jakobsen","year":"2016","unstructured":"Schatz-Jakobsen, J. A. et al. Structural basis for eculizumab-mediated inhibition of the complement terminal pathway. J. Immunol. 197, 337\u2013344 (2016).","journal-title":"J. Immunol."},{"key":"830_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-01087-7","volume":"7","author":"T Fukuzawa","year":"2017","unstructured":"Fukuzawa, T. et al. Long lasting neutralization of C5 by SKY59, a novel recycling antibody, is a potential therapy for complement-mediated diseases. Sci. Rep. 7, 1080 (2017).","journal-title":"Sci. Rep."},{"key":"830_CR21","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/imm.13083","volume":"157","author":"WM Zelek","year":"2019","unstructured":"Zelek, W. M., Taylor, P. R. & Morgan, B. P. Development and characterization of novel anti-C5 monoclonal antibodies capable of inhibiting complement in multiple species. Immunology 157, 283\u2013295 (2019).","journal-title":"Immunology"},{"key":"830_CR22","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s00467-017-3813-2","volume":"33","author":"G Ardissino","year":"2018","unstructured":"Ardissino, G. et al. Complement functional tests for monitoring eculizumab treatment in patients with atypical hemolytic uremic syndrome: an update. Pediatr. Nephrol. 33, 457\u2013461 (2018).","journal-title":"Pediatr. Nephrol."},{"key":"830_CR23","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3389\/fimmu.2016.00036","volume":"7","author":"KE Lintner","year":"2016","unstructured":"Lintner, K. E. et al. Early components of the complement classical activation pathway in human systemic autoimmune diseases. Front Immunol. 7, 36 (2016).","journal-title":"Front Immunol."},{"key":"830_CR24","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1086\/518257","volume":"80","author":"Y Yang","year":"2007","unstructured":"Yang, Y. et al. Gene copy-number variation and associated polymorphisms of complement component C4 in human systemic lupus erythematosus (SLE): low copy number is a risk factor for and high copy number is a protective factor against SLE susceptibility in European Americans. Am. J. Hum. Genet. 80, 1037\u20131054 (2007).","journal-title":"Am. J. Hum. Genet."},{"key":"830_CR25","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.molimm.2008.11.018","volume":"46","author":"K Saxena","year":"2009","unstructured":"Saxena, K. et al. Great genotypic and phenotypic diversities associated with copy-number variations of complement C4 and RP-C4-CYP21-TNX (RCCX) modules: a comparison of Asian-Indian and European American populations. Mol. Immunol. 46, 1289\u20131303 (2009).","journal-title":"Mol. Immunol."},{"key":"830_CR26","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1055\/s-0039-1692426","volume":"119","author":"AEA Dahm","year":"2019","unstructured":"Dahm, A. E. A. et al. Elevated complement C3 and C4 levels are associated with postnatal pregnancy-related venous thrombosis. Thromb. Haemost. 119, 1481\u20131488 (2019).","journal-title":"Thromb. Haemost."},{"key":"830_CR27","doi-asserted-by":"publisher","first-page":"885","DOI":"10.3389\/fimmu.2019.00885","volume":"10","author":"SL Savelli","year":"2019","unstructured":"Savelli, S. L. et al. Opposite profiles of complement in antiphospholipid syndrome (APS) and systemic lupus erythematosus (SLE) among patients with antiphospholipid antibodies (aPL). Front Immunol. 10, 885 (2019).","journal-title":"Front Immunol."},{"key":"830_CR28","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1084\/jem.165.3.848","volume":"165","author":"ME Medof","year":"1987","unstructured":"Medof, M. E., Walter, E. I., Rutgers, J. L., Knowles, D. M. & Nussenzweig, V. Identification of the complement decay-accelerating factor (DAF) on epithelium and glandular cells and in body fluids. J. Exp. Med. 165, 848\u2013864 (1987).","journal-title":"J. Exp. Med."},{"key":"830_CR29","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1101\/gr.126573.111","volume":"22","author":"AD Kostic","year":"2012","unstructured":"Kostic, A. D. et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res 22, 292\u2013298 (2012).","journal-title":"Genome Res"},{"key":"830_CR30","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1126\/science.1224820","volume":"338","author":"JC Arthur","year":"2012","unstructured":"Arthur, J. C. et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 338, 120\u2013123 (2012).","journal-title":"Science"},{"key":"830_CR31","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/s41586-019-1237-9","volume":"569","author":"J Lloyd-Price","year":"2019","unstructured":"Lloyd-Price, J. et al. Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature 569, 655\u2013662 (2019).","journal-title":"Nature"},{"key":"830_CR32","doi-asserted-by":"publisher","first-page":"193ra191","DOI":"10.1126\/scitranslmed.3006438","volume":"5","author":"I Vujkovic-Cvijin","year":"2013","unstructured":"Vujkovic-Cvijin, I. et al. Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism. Sci. Transl. Med. 5, 193ra191 (2013).","journal-title":"Sci. Transl. Med."},{"key":"830_CR33","doi-asserted-by":"publisher","first-page":"eaax5727","DOI":"10.1126\/sciadv.aax5727","volume":"5","author":"MR Olm","year":"2019","unstructured":"Olm, M. R. et al. Necrotizing enterocolitis is preceded by increased gut bacterial replication, Klebsiella, and fimbriae-encoding bacteria. Sci. Adv. 5, eaax5727 (2019).","journal-title":"Sci. Adv."},{"key":"830_CR34","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.tibtech.2015.06.011","volume":"33","author":"NR Shin","year":"2015","unstructured":"Shin, N. R., Whon, T. W. & Bae, J. W. Proteobacteria: microbial signature of dysbiosis in gut microbiota. Trends Biotechnol. 33, 496\u2013503 (2015).","journal-title":"Trends Biotechnol."},{"key":"830_CR35","doi-asserted-by":"publisher","first-page":"aad3311","DOI":"10.1126\/science.aad3311","volume":"351","author":"LV Blanton","year":"2016","unstructured":"Blanton, L. V. et al. Gut bacteria that prevent growth impairments transmitted by microbiota from malnourished children. Science 351, aad3311 (2016).","journal-title":"Science"},{"key":"830_CR36","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1182\/blood-2003-01-0223","volume":"102","author":"C Heeschen","year":"2003","unstructured":"Heeschen, C. et al. Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 102, 1340\u20131346 (2003).","journal-title":"Blood"},{"key":"830_CR37","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1182\/blood.V93.8.2627","volume":"93","author":"D Ribatti","year":"1999","unstructured":"Ribatti, D. et al. Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Blood 93, 2627\u20132636 (1999).","journal-title":"Blood"},{"key":"830_CR38","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1182\/blood.V4.10.1085.1085","volume":"4","author":"F Homburger","year":"1949","unstructured":"Homburger, F. & Petermann, M. L. Studies on hypoproteinemia; familial idiopathic dysproteinemia. Blood 4, 1085\u20131108 (1949).","journal-title":"Blood"},{"key":"830_CR39","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1136\/adc.41.215.54","volume":"41","author":"AM Parfitt","year":"1966","unstructured":"Parfitt, A. M. Familial neonatal hypoproteinaemia with exudative enteropathy and intestinal lymphangiectasis. Arch. Dis. Child 41, 54\u201362 (1966).","journal-title":"Arch. Dis. Child"},{"key":"830_CR40","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2174\/1389203053545426","volume":"6","author":"M Srinivasan","year":"2005","unstructured":"Srinivasan, M. & Roeske, R. W. Immunomodulatory peptides from IgSF proteins: a review. Curr. Protein Pept. Sci. 6, 185\u2013196 (2005).","journal-title":"Curr. Protein Pept. Sci."},{"key":"830_CR41","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1161\/CIRCULATIONAHA.118.034600","volume":"138","author":"RJ Sauter","year":"2018","unstructured":"Sauter, R. J. et al. Functional relevance of the anaphylatoxin receptor C3aR for platelet function and arterial thrombus formation marks an intersection point between innate immunity and thrombosis. Circulation 138, 1720\u20131735 (2018).","journal-title":"Circulation"},{"key":"830_CR42","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1053\/j.seminhematol.2018.05.014","volume":"55","author":"R Notaro","year":"2018","unstructured":"Notaro, R. & Sica, M. C3-mediated extravascular hemolysis in PNH on eculizumab: mechanism and clinical implications. Semin Hematol. 55, 130\u2013135 (2018).","journal-title":"Semin Hematol."},{"key":"830_CR43","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1002\/jimd.12225","volume":"43","author":"WJ Brucker","year":"2020","unstructured":"Brucker, W. J. et al. An emerging role for endothelial barrier support therapy for congenital disorders of glycosylation. J. Inherit. Metab. Dis. 43, 880\u2013890 (2020).","journal-title":"J. Inherit. Metab. Dis."},{"key":"830_CR44","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/cei.12743","volume":"184","author":"H Ding","year":"2016","unstructured":"Ding, H., Kharboutli, M., Saxena, R. & Wu, T. Insulin-like growth factor binding protein-2 as a novel biomarker for disease activity and renal pathology changes in lupus nephritis. Clin. Exp. Immunol. 184, 11\u201318 (2016).","journal-title":"Clin. Exp. Immunol."},{"key":"830_CR45","doi-asserted-by":"publisher","first-page":"3332","DOI":"10.1210\/en.2011-1121","volume":"152","author":"WJ Azar","year":"2011","unstructured":"Azar, W. J. et al. IGFBP-2 enhances VEGF gene promoter activity and consequent promotion of angiogenesis by neuroblastoma cells. Endocrinology 152, 3332\u20133342 (2011).","journal-title":"Endocrinology"},{"key":"830_CR46","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1056\/NEJMoa1615887","volume":"377","author":"A Ozen","year":"2017","unstructured":"Ozen, A., Comrie, W. A. & Lenardo, M. J. CD55 deficiency and protein-losing enteropathy. N. Engl. J. Med. 377, 1499\u20131500 (2017).","journal-title":"N. Engl. J. Med."},{"key":"830_CR47","doi-asserted-by":"publisher","first-page":"C578","DOI":"10.1152\/ajpcell.00339.2001","volume":"282","author":"JC Mason","year":"2002","unstructured":"Mason, J. C., Lidington, E. A., Ahmad, S. R. & Haskard, D. O. bFGF and VEGF synergistically enhance endothelial cytoprotection via decay-accelerating factor induction. Am. J. Physiol. Cell Physiol. 282, C578\u2013C587 (2002).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"830_CR48","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1182\/blood.V94.5.1673","volume":"94","author":"JC Mason","year":"1999","unstructured":"Mason, J. C. et al. Induction of decay-accelerating factor by cytokines or the membrane-attack complex protects vascular endothelial cells against complement deposition. Blood 94, 1673\u20131682 (1999).","journal-title":"Blood"},{"key":"830_CR49","doi-asserted-by":"publisher","first-page":"e94781","DOI":"10.1371\/journal.pone.0094781","volume":"9","author":"SM Park","year":"2014","unstructured":"Park, S. M. et al. Mapping the distinctive populations of lymphatic endothelial cells in different zones of human lymph nodes. PLoS ONE 9, e94781 (2014).","journal-title":"PLoS ONE"},{"key":"830_CR50","doi-asserted-by":"publisher","first-page":"17121","DOI":"10.1038\/nmicrobiol.2017.121","volume":"2","author":"JR Zaneveld","year":"2017","unstructured":"Zaneveld, J. R., McMinds, R. & Vega Thurber, R. Stress and stability: applying the Anna Karenina principle to animal microbiomes. Nat. Microbiol. 2, 17121 (2017).","journal-title":"Nat. Microbiol."},{"key":"830_CR51","unstructured":"Eser, E. et al. The psychometric properties of the new Turkish generic health-related quality of life questionnaire for children (Kid-KINDL). Turk Psikiyatri Derg 19, 409\u2013417 (2008)."},{"key":"830_CR52","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1128\/CDLI.6.1.137-139.1999","volume":"6","author":"TD Jaskowski","year":"1999","unstructured":"Jaskowski, T. D., Martins, T. B., Litwin, C. M. & Hill, H. R. Comparison of three different methods for measuring classical pathway complement activity. Clin. Diagn. Lab. Immunol. 6, 137\u2013139 (1999).","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"830_CR53","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1089\/cmb.2012.0021","volume":"19","author":"A Bankevich","year":"2012","unstructured":"Bankevich, A. et al. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J. Comput Biol. 19, 455\u2013477 (2012).","journal-title":"J. Comput Biol."},{"key":"830_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1891-0","volume":"20","author":"DE Wood","year":"2019","unstructured":"Wood, D. E., Lu, J. & Langmead, B. Improved metagenomic analysis with Kraken 2. Genome Biol. 20, 257 (2019).","journal-title":"Genome Biol."},{"key":"830_CR55","doi-asserted-by":"publisher","first-page":"e1000465","DOI":"10.1371\/journal.pcbi.1000465","volume":"5","author":"Y Ye","year":"2009","unstructured":"Ye, Y. & Doak, T. G. A parsimony approach to biological pathway reconstruction\/inference for genomes and metagenomes. PLoS Comput. Biol. 5, e1000465 (2009).","journal-title":"PLoS Comput. Biol."},{"key":"830_CR56","doi-asserted-by":"publisher","first-page":"D590","DOI":"10.1093\/nar\/gky962","volume":"47","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M., Sato, Y., Furumichi, M., Morishima, K. & Tanabe, M. New approach for understanding genome variations in KEGG. Nucleic Acids Res. 47, D590\u2013D595 (2019).","journal-title":"Nucleic Acids Res."},{"key":"830_CR57","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/1471-2105-11-119","volume":"11","author":"D Hyatt","year":"2010","unstructured":"Hyatt, D. et al. Prodigal: prokaryotic gene recognition and translation initiation site identification. BMC Bioinform. 11, 119 (2010).","journal-title":"BMC Bioinform."},{"key":"830_CR58","doi-asserted-by":"publisher","unstructured":"Kuznetsova, A., Brockhoff, P. & Christensen, R. lmerTest Package: tests in linear mixed effects models. J. Stat. Softw. https:\/\/doi.org\/10.18637\/jss.v082.i13 (2017).","DOI":"10.18637\/jss.v082.i13"},{"key":"830_CR59","doi-asserted-by":"publisher","first-page":"e15004","DOI":"10.1371\/journal.pone.0015004","volume":"5","author":"L Gold","year":"2010","unstructured":"Gold, L. et al. Aptamer-based multiplexed proteomic technology for biomarker discovery. PLoS ONE 5, e15004 (2010).","journal-title":"PLoS ONE"},{"key":"830_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-14755-5","volume":"7","author":"J Candia","year":"2017","unstructured":"Candia, J. et al. Assessment of variability in the SOMAscan assay. Sci. Rep. 7, 14248 (2017).","journal-title":"Sci. Rep."},{"key":"830_CR61","doi-asserted-by":"publisher","first-page":"20","DOI":"10.5334\/jors.166","volume":"5","author":"F Cheung","year":"2017","unstructured":"Cheung, F. et al. Web tool for navigating and plotting SomaLogic ADAT files. J. Open Res Softw. 5, 20 (2017).","journal-title":"J. Open Res Softw."},{"key":"830_CR62","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1182\/blood-2014-02-558296","volume":"124","author":"M Noris","year":"2014","unstructured":"Noris, M. et al. Dynamics of complement activation in aHUS and how to monitor eculizumab therapy. Blood 124, 1715\u20131726 (2014).","journal-title":"Blood"},{"key":"830_CR63","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1126\/science.aaq1327","volume":"361","author":"V Emilsson","year":"2018","unstructured":"Emilsson, V. et al. Co-regulatory networks of human serum proteins link genetics to disease. Science 361, 769\u2013773 (2018).","journal-title":"Science"},{"key":"830_CR64","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1158\/1078-0432.CCR-06-2286","volume":"13","author":"JL Eiseman","year":"2007","unstructured":"Eiseman, J. L. et al. Evaluation of plasma insulin-like growth factor binding protein 2 and Her-2 extracellular domain as biomarkers for 17-allylamino-17-demethoxygeldanamycin treatment of adult patients with advanced solid tumors. Clin. Cancer Res 13, 2121\u20132127 (2007).","journal-title":"Clin. Cancer Res"},{"key":"830_CR65","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/pro.3235","volume":"27","author":"TD Goddard","year":"2018","unstructured":"Goddard, T. D. et al. UCSF ChimeraX: meeting modern challenges in visualization and analysis. Protein Sci. 27, 14\u201325 (2018).","journal-title":"Protein Sci."},{"key":"830_CR66","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.str.2011.03.019","volume":"19","author":"MV Shapovalov","year":"2011","unstructured":"Shapovalov, M. V. & Dunbrack, R. L. Jr. A smoothed backbone-dependent rotamer library for proteins derived from adaptive kernel density estimates and regressions. Structure 19, 844\u2013858 (2011).","journal-title":"Structure"},{"key":"830_CR67","first-page":"649","volume":"32","author":"I Tezcan","year":"1996","unstructured":"Tezcan, I., Berkel, A. I., Ersoy, F. & Sanal, O. Sa\u011fl\u0131kl\u0131 T\u00fcrk \u00e7ocuklar\u0131 ve eri\u015fkinlerde turbidometrik y\u00f6ntemle bak\u0131lan serum immunoglobulin d\u00fczeyleri. \u00c7ocuk Sa\u011fl\u0131\u011f\u0131 ve Hastal\u0131klar\u0131 Derg. 32, 649\u2013656 (1996).","journal-title":"\u00c7ocuk Sa\u011fl\u0131\u011f\u0131 ve Hastal\u0131klar\u0131 Derg."},{"key":"830_CR68","doi-asserted-by":"publisher","first-page":"D661","DOI":"10.1093\/nar\/gkx1064","volume":"46","author":"DN Slenter","year":"2017","unstructured":"Slenter, D. N. et al. WikiPathways: a multifaceted pathway database bridging metabolomics to other omics research. Nucleic Acids Res. 46, D661\u2013D667 (2017).","journal-title":"Nucleic Acids Res."},{"key":"830_CR69","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"830_CR70","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk, D. et al. STRING v11: protein\u2013protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 47, D607\u2013D613 (2019).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41590-020-00830-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-020-00830-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-020-00830-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T21:08:51Z","timestamp":1674853731000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41590-020-00830-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,4]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["830"],"URL":"https:\/\/doi.org\/10.1038\/s41590-020-00830-z","relation":{},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,4]]},"assertion":[{"value":"18 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors M.J.L. and A.O. have a pending patent on C5 inhibitor treatment of CHAPLE. B.S. is a former SomaLogic, Inc. (Boulder, CO, USA) employee and a company shareholder. O.H., Y.G.N., M.-D.W. and K.D.-N. are employees of Regeneron Pharmaceuticals Inc., a biopharma company. There are no conflicts of interest to report for the remaining coauthors.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}